Inflammation in multiple sclerosis: the good, the bad, and the complex
Gianvito Martino(Vita-Salute San Raffaele University), Massimo Filippi(Vita-Salute San Raffaele University), Gıancarlo Comı(Casa di Cura Columbus), Jan Hillert(Karolinska University Hospital), Luciano Adorini(Intercept Pharmaceuticals (United States)), Boris Kallmann(University of Würzburg)
Cited by 146
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k